Categories: EHRNews

Coloplast A/S – Q1 2024/25 Earnings Release – Invitation to conference call on 4 February 2025 at 11.00am CET (correction)

Tuesday, 4 February 2025 at 11.00 – 12.00am CET (corrected from 10.00 – 11.00am CET in an earlier version of this invitation)
In connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event. 

Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard  Executive Vice President, CFO
Aleksandra Dimovska – Vice President, Investor Relations
Simone Dyrby Helvind – Senior Manager, Investor Relations 

 

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here


Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

 

 

For more information, please contact:

Aleksandra Dimovska – Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com

Simone Dyrby Helvind – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com

Julie Isabella Sommer Müggler – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

Staff

Recent Posts

Medexus Schedules Third Fiscal Quarter 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP)…

5 hours ago

In HelloNation, Family Counseling Expert Scott Ostrowski of Geneva Outlines Employee and Employer Support Services for HelloNation

GENEVA, N.Y., Feb. 3, 2026 /PRNewswire/ -- What are Employee and Employer Support Services, and…

5 hours ago

In HelloNation, Dental Lab Specialist Jeffrey Tolksdorf of Clinton Township, MI, Details What Happens Inside a Dental Lab

CLINTON TOWNSHIP, Mich., Feb. 3, 2026 /PRNewswire/ -- What actually happens after your dentist takes…

5 hours ago

In HelloNation, Water Treatment Expert Jason McGee of Loretto Explains the Importance of Precision in Water Treatment Chemistry

LORETTO, Tenn., Feb. 3, 2026 /PRNewswire/ -- How does precision in chemical dosing affect the…

5 hours ago

GLOBO Language Solutions Elevates Leadership with Executive Promotions

PHILADELPHIA, Feb. 3, 2026 /PRNewswire/ -- GLOBO Language Solutions, the leading B2B provider of interpreting and…

5 hours ago

Specialty1 Partners Continues to Accelerate Growth Through Its Industry-Leading Joint Venture Model

HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Specialty1 Partners (S1P), the nation's fastest growing specialty dental…

5 hours ago